Chlamydia screening in primary care: Is it useful, affordable and universal?

Current Opinion in Infectious Diseases

Volumn 15, Issue 1, 2002, Pages 31-36

  Tobin, Jean M ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; GENITAL TRACT INFECTION; HUMAN; INFECTION RATE; PRIMARY MEDICAL CARE; REVIEW; SCREENING; SEXUAL BEHAVIOR; UNITED KINGDOM;

EID: 0036157687     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200202000-00006     Document Type: Review

References (58)

1. Screening for genital chlamydia infection
2. Genital chlamydia infections in sexually active female adolescents: Do we really need to screen everyone?
3. Sentinel surveillance of Chlamydia trachomatis infection in women terminating pregnancy
4. Trends in the prevalence of chlamydia infections. The impact of community-wide testing
5. Screening for chlamydial infection
6. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection
7. Chlamydia trachomatis infection and the risk of perinatal mortality in Hungary
8. Chlamydia, gonorrhoea, and HIV-1 prevalence among five populations of women in the Czech and Slovak republics
9. The acceptability of urinary LCR testing for Chlamydia trachomatis among participants in a probability sample survey of sexual attitudes and lifestyles
10. Screening for Chlamydia trachomatis in an anonymous and confidential HIV counselling and testing site: Feasibility and prevalence rates
11. Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics
12. Self collection of vaginal swabs for the detection of chlamydia, gonorrhoea and trichomoniasis
13. Assessment of Chlamydia trachomatis prevalence by PCR and LCR in women presenting for termination of pregnancy
14. Home screening for chlamydial genital infection: Is it acceptable to young men and women?
15. Detection of chlamydia on meatal swabs
16. Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population
17. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens
18. Acceptability of home screening for chlamydial infection: Some remaining issues
19. Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 Weeks' prospective follow up study
20. Changes in public awareness of Chlamydia during a national screening pilot study
21. Screening for Chlamydia trachomatis infection using the BDProbeTectrade mark ET Chlamydia trachomatis amplified DNA assay on urine in a GUM clinic setting: A simple, fast and cost-effective alternative
22. Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study
23. Economic advantages of ligase chain reaction for diagnosis of genital Chlamydial trachomatis infection in GUM clinic attenders
24. Temperature stability of vaginal specimens for Chlamydia trachomatis detection by Amplicor polymerase chain reaction assay
25. The future of Chlamydia screening
26. Drug treatment of genital chlamydial infection
27. The value of a screen and treat policy for Chlamydia trachomatis in women attending for termination of pregnancy
28. Incidence of recurrent diagnosis of Chlamydia trachomatis genital infections among male and female soldiers of the US army
29. Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females
30. Chlamydia trachomatis reinfection rate: A forgotten aspect of female genital chlamydia management
31. Evidence is not (yet) enough for evidence based policy for chlamydia screening
32. Which women should be tested for Chlamydia trachomatis?
33. Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis
34. Emergency department screening for asymptomatic sexually transmitted infections
35. Screening for sexually transmitted infections among economically disadvantaged youth in a national job training program
36. Genital Chlamydia trachomatis infections in Lithuanian women invited for screening via newspaper advertisement: A pilot study
37. Implementation of a screening program for chlamydial infection in incarcerated adolescents
38. The burden of reproductive-organ disease in rural women in The Gambia, West Africa
39. STD screening among HIV-infected patients in care, San Francisco
40. Cost-effectiveness of hysterosalpingography, laparoscopy, and Chlamydia antibody testing in subfertile couples
41. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women
42. Pooling urine samples for PCR screening of C. trachomatis urogenital infection in women
43. Impact of new sexually transmitted disease diagnostics on clinical practice and public health policy
44. Predictors of Chlamydia trachomatis infection among women attending rural Midwest family planning clinics
45. Is there a seasonal variation in gonorrhoea and chlamydia in adolescents?
46. Sexuality: The hidden costs of screening for Chlamydia trachomatis
47. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: Implications for screening
48. Prevalence of Chlamydia trachomatis in young men in north west London
49. The prevalence of Chlamydia trachomatis infection in male undergraduates: A postal survey
50. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections
51. Detection or treatment: Which outcome measure?
52. Barriers to screening sexually active adolescent women for chlamydia: A survey of primary care physicians
53. Predictors of the vaginal microflora